Form D · Biotechnology
ORF Biologics, Inc.
Tiffin, IA · CIK 0002048350
Offering snapshot reported Jul 31, 2026 · SEC filing
- Reported sold
- $1.73M Offering amount: $2.5M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 23, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 31, 2026 | Initial | $1,734,220 | No comparison | 17 | SEC filing |
| Dec 12, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-592854
Source: Form D, filed Jul 31, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Roger A. Baker | Director |
| Stephen Hanson | Director, Executive |
| John R. Huiskamp | Director |
| Anant Kamath | Director, Executive |
| Jay Kamath | Executive |
| Steven Michalicek | Director |
| Nicholas Taiber | Director |
| Sara Ternes | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1110 Tall Grass Drive
Tiffin, IA, 52340
Phone: 3199920004
Tiffin, IA, 52340
Phone: 3199920004